跳至主要内容
临床试验/NCT03180346
NCT03180346Unknown不适用

A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SURGICAL Dressing).

Rothman Institute Orthopaedics2 个研究点 分布在 1 个国家目标入组 494 人开始时间: 2017年3月21日最近更新:
适应症

试验速览

阶段
不适用
入组人数
494
试验地点
2
主要终点
Surgical Site Infection

研究概览

简要总结

The primary aim of this study is to determine if the SSI rate following revision total hip and knee arthroplasty is reduced in patients treated with the PICO device compared to patients with traditional postoperative dressings. Our secondary goals include; comparing the amount of wound drainage, rate of resolution of wound drainage, length of hospital stay, functional outcomes, and economic implications of wound drainage and SSI after revision arthroplasty comparing PICO and traditional dressings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient ≥18 years old
  • Male or non-pregnant, non-lactating, postmenopausal or surgically sterilized females
  • Subjects undergoing revision total knee arthroplasty or revision total hip arthroplasty
  • Subjects provide informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information
  • Subjects deemed able to understand and comply with study visit schedule and procedures

排除标准

  • Wounds that require daily inspection
  • Active bleeding within the surgical site
  • Pregnant, lactating females, or females of childbearing potential not willing to practice an effective method of contraception
  • Subjects on warfarin therapy. Resulting in increased exudate and prolonging hospital stay following surgery to achieve therapeutic INR levels
  • Skin integrity issues that preclude the use of Negative Pressure Wound Therapy (NPWT)
  • Subjects undergoing primary total joint procedures
  • Subjects with a known history of poor compliance with medical treatment
  • Subjects who have participated in this trial previously and who were withdrawn 9 . Subjects with known allergies to product components (silicone adhesives and polyurethane films (direct contact with wound), acrylic adhesives (direct contact with skin), polyethylene fabrics and super-absorbent powders (polyacrylates) (within the dressing)

结局指标

主要结局

Surgical Site Infection

时间窗: 90-day followup following revision surgery

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验